Skip to main content

Insecticides India Reports Q2 Revenue of ₹686 Crore, Profit Drops to ₹56.17 Crore

Insecticides India delivered top-line expansion in Q2 with revenue rising to ₹686 crore, supported by steady volume demand. Operational profit margins contracted slightly, pulling down net profit to ₹56.17 crore compared to ₹59.11 crore in the year-ago quarter.

Author Image
Sahi Markets
Published: 5 Nov 2026, 03:33 PM IST (33 minutes ago)
Last Updated: 5 Nov 2026, 03:33 PM IST (33 minutes ago)
2 min read
Reviewed by Arpit Seth

Market snapshot: Insecticides India reported a 7.52% YoY growth in Q2 consolidated revenue to ₹686 crore. However, consolidated net profit declined 4.97% YoY to ₹56.17 crore as operating margins faced pressure. EBITDA rose 3.31% YoY to ₹92.44 crore while EBITDA margin contracted by 56 basis points to 13.47%.

Data Snapshot

  • Q2 Consolidated Revenue reached ₹686 crore compared to ₹638 crore in the prior-year quarter.
  • Q2 Consolidated Net Profit came in at ₹56.17 crore against ₹59.11 crore in Q2 of the previous fiscal year.
  • Q2 EBITDA increased to ₹92.44 crore from ₹89.48 crore in the corresponding quarter last year.
  • Q2 EBITDA Margin compressed to 13.47% from 14.03% YoY.

What's Changed

  • Revenue expanded by ₹48 crore YoY (derived: ₹686 cr vs ₹638 cr).
  • Net profit decreased by ₹2.94 crore YoY (derived: ₹56.17 cr vs ₹59.11 cr).
  • EBITDA margin contracted by 56 bps YoY to 13.47%.

Key Takeaways

  • Top-line expanded 7.52% YoY to ₹686 crore, indicating resilience in product uptake during the quarter.
  • EBITDA grew modestly by 3.31% YoY to ₹92.44 crore, lagging revenue growth due to input cost pressures.
  • Net profit fell 4.97% YoY to ₹56.17 crore, constrained by margin dilution.

SAHI Perspective

Insecticides India's performance reflects a dual dynamics pattern typical of agrochemical manufacturers in monsoon transitions. Revenue growth of 7.52% demonstrates healthy volume movement in core formulations, but operational margin contraction of 56 basis points underscores cost-side inflation and competitive pricing pressures in key generic product portfolios.

Market Implications

The mixed quarterly performance could lead to near-term rangebound trading in the stock. Investors are likely to evaluate product mix improvements and raw material price stability ahead of the upcoming Rabi season.

Trading Signals

Market Bias: Neutral

Revenue growth of 7.52% YoY to ₹686 crore is offset by a 4.97% YoY drop in net profit to ₹56.17 crore and a 56 bps margin contraction to 13.47%.

Overweight: Agrochemicals & Crop Protection

Trigger Factors:

  • Raw material cost trend changes
  • Rabi crop sowing and formulation uptake momentum
  • Working capital and inventory turnover efficiency

Time Horizon: Near-term (0-3 months)

Industry Context

The crop protection industry faced mixed weather impacts during the Kharif season, influencing application frequency and regional distribution mix. Companies focusing on higher-value specialized formulations tend to preserve margins better than generic-heavy portfolios.

Key Risks to Watch

  • Continued raw material cost volatility eroding operating margins
  • Unseasonable rainfall affecting farm application schedules
  • Working capital extensions in distribution channels

Recent Developments

No verified developments in this window

Closing Insight

While top-line growth at ₹686 crore reinforces market position, restoring margin resilience toward historical levels will be essential for sustained earnings acceleration in subsequent quarters.

High Performance Trading with SAHI.

Disclaimer: This news section may include AI-generated or AI-assisted news, summaries, drafts, or insights. All content is subject to human review before publication. While we aim for accuracy, readers should independently verify information before relying on it.

Open Free Account

Frequently Asked Questions (FAQs)

All topics

Add Sahi as a Preferred Source on Google

Click the link, confirm the box next to sahi.com is checked — ignore any other results.